These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11877365)

  • 1. Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
    Bruban V; Estato V; Schann S; Ehrhardt JD; Monassier L; Renard P; Scalbert E; Feldman J; Bousquet P
    Circulation; 2002 Mar; 105(9):1116-21. PubMed ID: 11877365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.
    Bruban V; Feldman J; Greney H; Dontenwill M; Schann S; Jarry C; Payard M; Boutin J; Scalbert E; Pfeiffer B; Renard P; Vanhoutte P; Bousquet P
    Br J Pharmacol; 2001 May; 133(2):261-6. PubMed ID: 11350862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of renal sympathetic baroreflex effects of rilmenidine and alpha-methylnoradrenaline in the ventrolateral medulla of the rabbit.
    Head GA; Burke SL
    J Hypertens; 2000 Sep; 18(9):1263-76. PubMed ID: 10994758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite to alpha2-adrenergic agonists, an imidazoline I1 selective compound does not influence reflex bradycardia in rabbits.
    Sy GY; Bousquet P; Feldman J
    Auton Neurosci; 2006 Jul; 128(1-2):19-24. PubMed ID: 16464646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetized rabbit.
    Head GA; Burke SL
    J Hypertens; 1998 Apr; 16(4):503-17. PubMed ID: 9797196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA; Burke SL; Chan CK
    J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
    Sy GY; Bruban V; Bousquet P; Feldman J
    Hypertension; 2001 Feb; 37(2):246-9. PubMed ID: 11230279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbits.
    Sy GY; Bruban V; Bousquet P; Feldman J
    Neuropharmacology; 2002 Dec; 43(8):1330-8. PubMed ID: 12527483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central imidazoline receptors and centrally acting anti-hypertensive agents.
    Head GA; Burke SL; Chan CK
    Clin Exp Hypertens; 1997; 19(5-6):591-605. PubMed ID: 9247741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha 2A-adrenoceptors, not I1-imidazoline receptors, mediate the hypotensive effects of rilmenidine and moxonidine in conscious mice. In vivo and in vitro studies.
    Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
    Ann N Y Acad Sci; 1999 Jun; 881():287-9. PubMed ID: 10415927
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
    Szabo B; Bock C; Nordheim U; Niederhoffer N
    Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
    Estato V; Araújo CV; Bousquet P; Tibiriçá E
    Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Godwin SJ; Tortelli CF; Parkin ML; Head GA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):195-204. PubMed ID: 9851569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
    Parkin ML; Godwin SJ; Head GA
    J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits.
    Head GA; Burke SL; Sannajust FJ
    J Hypertens; 2001 Sep; 19(9):1615-24. PubMed ID: 11564982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.